These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 11063821

  • 1. Modulation of the IL-10/IL-12 cytokine circuit by interferon-beta inhibits the development of epitope spreading and disease progression in murine autoimmune encephalomyelitis.
    Tuohy VK, Yu M, Yin L, Mathisen PM, Johnson JM, Kawczak JA.
    J Neuroimmunol; 2000 Nov 01; 111(1-2):55-63. PubMed ID: 11063821
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Generation of autonomously pathogenic neo-autoreactive Th1 cells during the development of the determinant spreading cascade in murine autoimmune encephalomyelitis.
    Yu M, Johnson JM, Tuohy VK.
    J Neurosci Res; 1996 Aug 15; 45(4):463-70. PubMed ID: 8872907
    [Abstract] [Full Text] [Related]

  • 4. Pre-emptive targeting of the epitope spreading cascade with genetically modified regulatory T cells during autoimmune demyelinating disease.
    Yin L, Yu M, Edling AE, Kawczak JA, Mathisen PM, Nanavati T, Johnson JM, Tuohy VK.
    J Immunol; 2001 Dec 01; 167(11):6105-12. PubMed ID: 11714769
    [Abstract] [Full Text] [Related]

  • 5. 5-aminoimidazole-4-carboxamide ribonucleoside: a novel immunomodulator with therapeutic efficacy in experimental autoimmune encephalomyelitis.
    Nath N, Giri S, Prasad R, Salem ML, Singh AK, Singh I.
    J Immunol; 2005 Jul 01; 175(1):566-74. PubMed ID: 15972693
    [Abstract] [Full Text] [Related]

  • 6. Determinant-regulated onset of experimental autoimmune encephalomyelitis: distinct epitopes of myelin proteolipid protein mediate either acute or delayed disease in SJL/J mice.
    Tuohy VK, Thomas DM, Haqqi T, Yu M, Johnson JM.
    Autoimmunity; 1995 Jul 01; 21(3):203-14. PubMed ID: 8822278
    [Abstract] [Full Text] [Related]

  • 7. A predictable sequential determinant spreading cascade invariably accompanies progression of experimental autoimmune encephalomyelitis: a basis for peptide-specific therapy after onset of clinical disease.
    Yu M, Johnson JM, Tuohy VK.
    J Exp Med; 1996 Apr 01; 183(4):1777-88. PubMed ID: 8666934
    [Abstract] [Full Text] [Related]

  • 8. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
    Zhang X, Koldzic DN, Izikson L, Reddy J, Nazareno RF, Sakaguchi S, Kuchroo VK, Weiner HL.
    Int Immunol; 2004 Feb 01; 16(2):249-56. PubMed ID: 14734610
    [Abstract] [Full Text] [Related]

  • 9. IFN-β regulates Th17 differentiation partly through the inhibition of osteopontin in experimental autoimmune encephalomyelitis.
    Zhao Q, Cheng W, Xi Y, Cao Z, Xu Y, Wu T, Li C, Niu X, Chen G.
    Mol Immunol; 2018 Jan 01; 93():20-30. PubMed ID: 29127843
    [Abstract] [Full Text] [Related]

  • 10. IFN-beta gene deletion leads to augmented and chronic demyelinating experimental autoimmune encephalomyelitis.
    Teige I, Treschow A, Teige A, Mattsson R, Navikas V, Leanderson T, Holmdahl R, Issazadeh-Navikas S.
    J Immunol; 2003 May 01; 170(9):4776-84. PubMed ID: 12707359
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD.
    J Immunol; 2000 Jan 15; 164(2):670-8. PubMed ID: 10623809
    [Abstract] [Full Text] [Related]

  • 15. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K, Chandler P, Altmann DM.
    Eur J Immunol; 1997 Nov 15; 27(11):2927-34. PubMed ID: 9394820
    [Abstract] [Full Text] [Related]

  • 16. IL-4 abrogates the inhibitory effect of IL-10 on the development of experimental allergic encephalomyelitis in SJL mice.
    Nagelkerken L, Blauw B, Tielemans M.
    Int Immunol; 1997 Sep 15; 9(9):1243-51. PubMed ID: 9310827
    [Abstract] [Full Text] [Related]

  • 17. IL-4, IL-10, IL-13, and TGF-beta from an altered peptide ligand-specific Th2 cell clone down-regulate adoptive transfer of experimental autoimmune encephalomyelitis.
    Young DA, Lowe LD, Booth SS, Whitters MJ, Nicholson L, Kuchroo VK, Collins M.
    J Immunol; 2000 Apr 01; 164(7):3563-72. PubMed ID: 10725711
    [Abstract] [Full Text] [Related]

  • 18. Regression and spreading of self-recognition during the development of autoimmune demyelinating disease.
    Tuohy VK, Yu M, Yin L, Kawczak JA, Kinkel PR.
    J Autoimmun; 1999 Aug 01; 13(1):11-20. PubMed ID: 10441163
    [Abstract] [Full Text] [Related]

  • 19. Role of IL-12 receptor beta 1 in regulation of T cell response by APC in experimental autoimmune encephalomyelitis.
    Zhang GX, Yu S, Gran B, Li J, Siglienti I, Chen X, Calida D, Ventura E, Kamoun M, Rostami A.
    J Immunol; 2003 Nov 01; 171(9):4485-92. PubMed ID: 14568921
    [Abstract] [Full Text] [Related]

  • 20. Ethanol extract of Glycyrrhizae Radix modulates the responses of antigen-specific splenocytes in experimental autoimmune encephalomyelitis.
    Yang EJ, Song IS, Song KS.
    Phytomedicine; 2019 Feb 15; 54():56-65. PubMed ID: 30668383
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.